Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,870
archived clinical trials in
Pain

Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
mi
from
Edegem,
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
mi
from
Edegem,
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Beverly Hills, CA
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated:  3/13/2018
Clinical Research Facility
mi
from
Bronx, NY
Efficacy and Safety of 2 Doses of AQX-1125 in Subjects With Interstitial Cystitis / Bladder Pain Syndrome
The LEADERSHIP 301 Trial: A 12-Week, Randomized, Multi-Center, Double-Blind, Placebo-Controlled, 3-Arm, Parallel-Group, Phase 3 Trial to Evaluate the Efficacy and Safety of 2 Doses of AQX-1125 Targeting the Src Homology 2-containing Inositol-5'-Phosphatase 1 (SHIP1) Pathway in Subjects With Interstitial Cystitis/Bladder Pain Syndrome Followed by an Extension Period
Status: Enrolling
Updated: 3/13/2018
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling
Updated:  3/19/2018
University of California, Irvine Medical Center
mi
from
Orange, CA
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of IC/PBS
Pilot Study of Percutaneous Posterior Tibial Nerve Stimulation for the Treatment of Interstitial Cystitis/Painful Bladder Syndrome
Status: Enrolling
Updated: 3/19/2018
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
Status: Enrolling
Updated:  3/19/2018
Avery Road Treatment Center
mi
from
Rockville, MD
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
Status: Enrolling
Updated: 3/19/2018
Avery Road Treatment Center
mi
from
Rockville, MD
Click here to add this to my saved trials
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
Status: Enrolling
Updated:  3/19/2018
Kolmac Clinic
mi
from
Silver Spring, MD
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
The Effects of Opioid Taper on Opioid-Induced Hyperalgesia
Status: Enrolling
Updated: 3/19/2018
Kolmac Clinic
mi
from
Silver Spring, MD
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Hot Springs, AR
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
La Jolla, CA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Los Angeles, CA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Napa, CA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Napa, CA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Temecula, CA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Temecula, CA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Clermont, FL
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Clermont, FL
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Miami, FL
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Orlando, FL
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Tampa, FL
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Canton, GA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Canton, GA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Marietta, GA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
mi
from
Saint Marys, GA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
mi
from
Saint Marys, GA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Meridian, ID
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Meridian, ID
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Chicago, IL
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Louisville, KY
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Albuquerque, NM
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
New York, NY
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Portland, OR
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Dallas, TX
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
San Antonio, TX
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Bellevue, WA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Seattle, WA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Madison, WI
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
mi
from
Broadmeadow,
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
mi
from
Broadmeadow,
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Tucson, AZ
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Encinitas, CA
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated:  3/21/2018
Clinical Research Facility
mi
from
Denver, CO
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
CREATE-1 Study: CRPS Treatment Evaluation 1 Study. A Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of AXS-02 (Oral Zoledronate) Administered Orally to Subjects With Complex Regional Pain Syndrome Type I (CRPS-I)
Status: Enrolling
Updated: 3/21/2018
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination (Factorial Design) Clinical Trial
Status: Enrolling
Updated:  3/21/2018
Translational Pain Research, Brigham and Women's Hospital
mi
from
Boston, MA
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial
Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination (Factorial Design) Clinical Trial
Status: Enrolling
Updated: 3/21/2018
Translational Pain Research, Brigham and Women's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Birmingham, AL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Mobile, AL
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Phoenix, AZ
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Anaheim, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Anaheim, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Fresno, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Fresno, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Los Alamitos, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Los Angeles, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Newport Beach, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Newport Beach, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Rancho Mirage, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Roseville, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Roseville, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
San Diego, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated:  3/27/2018
Clinical Research Facility
mi
from
Santa Ana, CA
An Open-Label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
An Open-label Extension Study of DS-5565 for 52 Weeks in Pain Associated With Fibromyalgia
Status: Enrolling
Updated: 3/27/2018
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials